Trendlyne Blog: , Latest on stock market and finance in India and the world.

Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets

IND

USA

Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding

Alkem Laboratories Ltd.

07 Feb 2025

5541.50

1.13%

Alkem Labs announces acquisitions in skincare and medical devices segments

Business Line

To acquire 100% stake in Adroit Biomed, a pharmaceutical company focussed on the skincare segment, for around 140 crore

Copy LinkShare on

Share on Share on Share on

Alkem Laboratories L.. has an average target of 5296.00 from 2 brokers.

Alkem Laboratories Q3 net profit rises 5.2%, revenue sees marginal growth

Business Standard | 07 Feb 2025 1 more

Alkem Labs Q3 Results: Net profit rises just 6% to 641 crore, total income flat; stock declines 4%

livemint | 07 Feb 2025

Akums Drugs & Pharmaceuticals Ltd.

07 Feb 2025

476.50

0.33%

Akums Drugs and Pharma Q3 Results: Adjusted Profit Rises 15% To Rs 66.3 Crore

NDTV Profit

Adjusted profit is calculated as the profit for the quarter/period plus fair value changes to financial instruments less tax impact on account of business merger, the filing said.

Copy LinkShare on

Share on Share on Share on

Akums Drugs & Pharmaceuticals Ltd. is trading below its 50 day SMA of 498.3

Akums Drugs slips 3% after posting 66% decline in Q3 profits, rev down 7%

Business Standard | 07 Feb 2025

Wockhardt Ltd.

07 Feb 2025

1505.70

-1.36%

Wockhardt Q3 Results: Pharma Major Swings Back To Profit As Expenses Fall

NDTV Profit

On the operating side, Ebitda jumped 84.6% to Rs 96 crore, while margin expanded to 13.3% from 7.4%.

Copy LinkShare on

Share on Share on Share on

Wockhardt Ltd. is trading above its 200 day SMA of 1469.4

Cipla Ltd.

07 Feb 2025

1575.80

-0.15%

Cipla stock shows strength on charts, adopt Bull Spread: Nandish Shah

Business Standard

Cipla share price: The short-term trend turned positive as Cipla stock price closed above its 5 and 11 day EMA

Copy LinkShare on

Share on Share on Share on

Cipla Ltd. has an average target of 1702.60 from 10 brokers.

Aurobindo Pharma Ltd.

06 Feb 2025

1119.20

-0.86%

Aurobindo Pharma Q3FY25 results: PAT falls 10% to Rs 845.56 crore

Business Standard

Company board approves purchase of 80 per cent share in step-down subsidiary Tergene Biotech

Copy LinkShare on

Share on Share on Share on

Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1126.0

Aurobindo Pharma Q3 Results: Profit Falls 9.7%, Misses Estimates

NDTV Profit | 06 Feb 2025

Emcure Pharmaceuticals Ltd.

06 Feb 2025

1342.50

0.12%

Emcure Pharmaceuticals Q3FY25: Profit grows 35.4%, revenue soars 17.6%

Business Standard

Sequentially, the revenue from operations fell by 1.9 per cent, with net profit also falling by 20.9 per cent

Copy LinkShare on

Share on Share on Share on

Emcure Pharmaceuticals Ltd. is trading above its 200 day SMA of 1245.6

AstraZeneca Pharma India Ltd.

06 Feb 2025

8934.50

-1.54%

AstraZeneca reports better than expected profit on higher cancer drug sales

Business Standard

Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts surveyed by Bloomberg

Copy LinkShare on

Share on Share on Share on

AstraZeneca Pharma India Ltd. is trading above all available SMAs

Dr. Reddy's Laboratories Ltd.

06 Feb 2025

1321.70

-0.08%

Dr Reddy's Unit Ties Up With Shanghai Henlius Biotech

NDTV Profit

As part of the tie-up, Henlius will be responsible for development, manufacturing and commercial supply, and may receive up to a total of $131.6 million.

Copy LinkShare on

Share on Share on Share on

Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.